Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05052255
Title RVU120 (SEL120) in Patients With Relapse/Refractory Metastatic or Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ryvu Therapeutics SA
Indications
Therapies
Age Groups: senior | adult
Covered Countries POL | ESP


No variant requirements are available.